Close this search box.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation® Canada

LAST CHANCE to TRIPLE your gift in 2023! Support a future of clinical trials!

Researcher working with lab specimens.

Today, November 30, 2023, marks the LAST DAY of our Triple Giving November campaign and the future has never looked brighter! The path forward is paved with clinical trials aimed at finding the most effective treatments fast. However, the success of these clinical trials hinges on the collective support from individuals like you.   Don’t miss […]

TRIPLE your gift & change lives like Ashanti’s – Act Before Match Runs Out!

Woman in pink dress

“I was living my best life…It was like being hit by a train I never saw coming.” Ashanti’s words show the reality faced by those battling ME/CFS and Long COVID daily. Her journey from being a vibrant NICU nurse, enjoying life in her 30s, to fighting an unseen, unheard enemy, is more than a story. It’s […]

Exclusive! Dr. Jonas Bergquist Discusses OMF’s First Clinical Trial

Jonas Bergquist in a white lab coat

  We invite you for an exclusive conversation with Jonas Bergquist, MD, Ph.D., OMF’s Chief Medical Officer and Director of the Uppsala University Collaboration. Today, Dr. Bergquist sheds light on The LifeImprovement Trial (LIFT), responding to key questions.  As a reminder, only THREE days remain in Triple Giving November, where every donation to OpenMedicine Foundation (OMF) is TRIPLED, […]

Don’t miss out! 3X the impact on research

“I once chased the perfect wave. Now, I chase the hope for a cure.”    Robert had to stop his passion of surfing, traveling, and working towards a promising business career because of ME/CFS. He says, “When I wasn’t surfing, I was working towards a business career and had three great job offers.” He even […]

Publications from Research Funded by Open Medicine Foundation

We are excited to share a comprehensive overview of the publications that have resulted from research funded by Open Medicine Foundation. Our dedicated team of researchers and collaborators has been at the forefront of uncovering the complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This eblast will guide you through the various categories of our publications, […]

Meet Sammy Lincroft: Advocate for ME/CFS and OMF Supporter!

mobility and ME/CFS

As part of this year’s Triple Giving November campaign, we are honored to introduce Sammy Lincroft, a dedicated advocate for chronic illnesses. Sammy is a strong supporter of Open Medicine Foundation in alignment with her advocacy for ME/CFS and disability justice. She runs a blog,, and an Instagram account, @m.e_and_more, where she provides valuable […]

Dr. David Systrom Discusses OMF’s LIFT Clinical Trial

David Systrom

Today Dr. David Systrom sits down to chat about OMF’s first clinical trial, The Life Improvement Trial (LIFT). What is The LIFT? Conducted under the direction of David Systrom, MD, Director of OMF’s Harvard Collaboration and Jonas Bergquist, MD, PhD, OMF’s Chief Medical Officer and Director of the Uppsala University Collaboration, The LIFT is a […]

How does OMF Choose Treatments for Clinical Trials? A Transparent Look

OMF Directors at Annual Gathering 2023

Our recent Research Directors Meeting this October was a testament to our commitment to collaborative discussions. As all the research directors gathered in person, a major part of the agenda was to discuss the methodology behind choosing treatments for clinical trials. We are excited to now share this process with you.  Last week, you may have […]

News! OMF’s First Clinical Trial!

We are thrilled to announce our very first clinical trial: The Life Improvement Trial (LIFT). This clinical treatment trial is a major step towards understanding and treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) more effectively. What is The LIFT? Conducted under the direction of David Systrom, MD, Director of our Harvard Collaboration and Jonas Bergquist, MD, […]